NCT07400588 Aleniglipron Phase 2 in Type 2 Diabetes Mellitus Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06693843 A Phase 2b, Dose-range Finding Study of the Efficacy and Safety of Multiple Doses of Aleniglipron (GSBR-1290) in Participants Living With Obesity or Overweight With at Least One Weight-related Comorbidity Status ACTIVE_NOT_RECRUITING Phase PHASE2